Treatment of acute hepatitis C with interferon alfa-2b
E Jaeckel, M Cornberg, H Wedemeyer… - … England Journal of …, 2001 - Mass Medical Soc
Background In people who are infected with the hepatitis C virus (HCV), chronic infection
often develops and is difficult to eradicate. We sought to determine whether treatment during …
often develops and is difficult to eradicate. We sought to determine whether treatment during …
High-dose interferon-α2b treatment prevents chronicity in acute hepatitis C: A pilot study
W Vogel, I Graziadei, F Umlauft, C Datz, F Hackl… - Digestive diseases and …, 1996 - Springer
Acute hepatitis C takes a chronic course in 50–80% of cases. Results with interferon
treatment are conflicting. To evaluate the efficacy of high-dose interferon treatment, we …
treatment are conflicting. To evaluate the efficacy of high-dose interferon treatment, we …
[PDF][PDF] Long‐term follow‐up after successful interferon therapy of acute hepatitis C
J Wiegand, E Jäckel, M Cornberg, H Hinrichsen… - …, 2004 - Wiley Online Library
Early treatment of acute hepatitis C infection with interferon alfa‐2b (IFN‐α‐2b) prevents
chronicity in almost all patients. So far, no data are available on the long‐term outcome after …
chronicity in almost all patients. So far, no data are available on the long‐term outcome after …
When and how to treat acute hepatitis C?
Background: Appropriate treatment of acute hepatitis C is still a matter of controversy due to
the lack of large controlled trials. Aim: To assess the effectiveness of interferon as treatment …
the lack of large controlled trials. Aim: To assess the effectiveness of interferon as treatment …
[PDF][PDF] Short‐term interferon‐alfa therapy for acute hepatitis C: a randomized controlled trial
H Nomura, S Sou, H Tanimoto, T Nagahama… - …, 2004 - Wiley Online Library
Acute hepatitis C often progresses to chronic infection. We undertook a randomized
controlled trial to determine whether short‐term therapy with interferon (IFN) during acute …
controlled trial to determine whether short‐term therapy with interferon (IFN) during acute …
Interferon as treatment for acute hepatitis C: a meta-analysis
The efficacy of short-course (three months), low-dose (3 million units three times a week)
interferon as treatment for acute hepatitis C was evaluated in a meta-analysis of controlled …
interferon as treatment for acute hepatitis C was evaluated in a meta-analysis of controlled …
Effects of interferon beta on non-A, non-B acute hepatitis: a prospective, randomized, controlled-dose study
S Takano, Y Satomura, M Omata - Gastroenterology, 1994 - Elsevier
Abstract Background/Aims: Non-A, non-B acute hepatitis progresses to a higher incidence of
chronicity and hepatocellular carcinoma. To avoid the development of chronic liver disease …
chronicity and hepatocellular carcinoma. To avoid the development of chronic liver disease …
Acute hepatitis C virus infection: Diagnosis, pathogenesis, treatment.
FA Cãruntu, L Benea - Journal of gastrointestinal and liver diseases …, 2006 - europepmc.org
Diagnosing acute hepatitis C is still difficult. The disease is frequently asymptomatic and
there are no specific diagnostic tests. Most frequently, diagnosis is based on anti HCV …
there are no specific diagnostic tests. Most frequently, diagnosis is based on anti HCV …
Therapy of acute hepatitis C
A Alberti, S Boccato, A Vario, L Benvegnù - Hepatology, 2002 - journals.lww.com
Acute hepatitis C has a high propensity to become chronic, which provides the rationale for
treating patients with acute disease attempting to prevent chronicity. Almost all published …
treating patients with acute disease attempting to prevent chronicity. Almost all published …
[PDF][PDF] Early monotherapy with pegylated interferon alpha‐2b for acute hepatitis C infection: the HEP‐NET acute‐HCV‐II study
J Wiegand, P Buggisch, W Boecher, S Zeuzem… - …, 2006 - Wiley Online Library
Early treatment of acute hepatitis C with interferon alpha‐2b for 24 weeks prevents chronic
infection in almost all patients. Because pegylated interferons have replaced conventional …
infection in almost all patients. Because pegylated interferons have replaced conventional …